The next generation of Lyme + Co-Infection Diagnostics—designed to detect at every stage
Combining direct and indirect testing methods, specifically for Bartonella infection, enhances diagnostic accuracy, especially for patients with complex clinical presentations. MosaicDX recommends maximizing diagnostic data by testing for both antibodies (indirect) and DNA evidence of infection (direct) for Bartonella, as each test method provides critical support. Tickborne BBB Direct Detect dPCR includes tests for Borrelia, Babesia and Bartonella at a genus level for all associated pathogens and Bartonella IgG Detect uses the IFA method to detect IgG to the top four (4) Bartonella species affecting humans in North America.
Tickborne BBB Direct Detect – dPCR (3 day) and Bartonella IgG Detect – IFA
Tickborne BBB Direct Detect dPCR, confirms current infection by directly detecting genus-level DNA for a broad range of Bartonella, Borrelia, and Babesia species (spp) in whole blood. This approach ensures that positive cases of infection with less common species are not missed.
Bartonella IgG Detect IFA confirms antibodies against the four most common species of infection: Bartonella henselae, Bartonella koehlerae, Bartonella quintana, and Bartonella vinsonii berkhoffii.
We offer nine (9) individual tests and combinations of the most common Lyme and co-infections in North America, with options designed to meet every practitioner’s need.
